BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20421209)

  • 1. Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element.
    Lanzino M; Sisci D; Morelli C; Garofalo C; Catalano S; Casaburi I; Capparelli C; Giordano C; Giordano F; Maggiolini M; Andò S
    Nucleic Acids Res; 2010 Sep; 38(16):5351-65. PubMed ID: 20421209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
    De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
    BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation.
    Lanzino M; Maris P; Sirianni R; Barone I; Casaburi I; Chimento A; Giordano C; Morelli C; Sisci D; Rizza P; Bonofiglio D; Catalano S; Andò S
    Cell Death Dis; 2013 Jul; 4(7):e724. PubMed ID: 23846226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SGK3 is an androgen-inducible kinase promoting prostate cancer cell proliferation through activation of p70 S6 kinase and up-regulation of cyclin D1.
    Wang Y; Zhou D; Chen S
    Mol Endocrinol; 2014 Jun; 28(6):935-48. PubMed ID: 24739041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells.
    Kim YC; Chen C; Bolton EC
    PLoS One; 2015; 10(9):e0138286. PubMed ID: 26372468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter.
    Cicatiello L; Addeo R; Sasso A; Altucci L; Petrizzi VB; Borgo R; Cancemi M; Caporali S; Caristi S; Scafoglio C; Teti D; Bresciani F; Perillo B; Weisz A
    Mol Cell Biol; 2004 Aug; 24(16):7260-74. PubMed ID: 15282324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells.
    Hsiang CH; Straus DS
    Oncogene; 2002 Mar; 21(14):2212-26. PubMed ID: 11948404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines.
    Rizza P; Barone I; Zito D; Giordano F; Lanzino M; De Amicis F; Mauro L; Sisci D; Catalano S; Dahlman Wright K; Gustafsson JA; Andò S
    Breast Cancer Res; 2014 Feb; 16(1):R21. PubMed ID: 24552459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulated expression of the prostacyclin receptor (IP) gene by androgens within the vasculature: Combined role for androgens and serum cholesterol.
    Eivers SB; Kinsella BT
    Biochim Biophys Acta; 2016 Oct; 1859(10):1333-51. PubMed ID: 27365208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of cyclin D1 for androgen receptor regulation.
    Petre-Draviam CE; Cook SL; Burd CJ; Marshall TW; Wetherill YB; Knudsen KE
    Cancer Res; 2003 Aug; 63(16):4903-13. PubMed ID: 12941814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function.
    Comstock CES; Augello MA; Schiewer MJ; Karch J; Burd CJ; Ertel A; Knudsen ES; Jessen WJ; Aronow BJ; Knudsen KE
    J Biol Chem; 2011 Mar; 286(10):8117-8127. PubMed ID: 21212260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative Effect of Androgen Receptor Inhibition in Mesenchymal Stem-Like Triple-Negative Breast Cancer.
    Zhu A; Li Y; Song W; Xu Y; Yang F; Zhang W; Yin Y; Guan X
    Cell Physiol Biochem; 2016; 38(3):1003-14. PubMed ID: 26938985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation.
    Burd CJ; Petre CE; Morey LM; Wang Y; Revelo MP; Haiman CA; Lu S; Fenoglio-Preiser CM; Li J; Knudsen ES; Wong J; Knudsen KE
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2190-5. PubMed ID: 16461912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching.
    Li Y; Zhang DY; Ren Q; Ye F; Zhao X; Daniels G; Wu X; Dynlacht B; Lee P
    Mol Cell Biol; 2012 Jul; 32(13):2454-66. PubMed ID: 22508987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.
    Rampalli S; Pavithra L; Bhatt A; Kundu TK; Chattopadhyay S
    Mol Cell Biol; 2005 Oct; 25(19):8415-29. PubMed ID: 16166625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.
    Eeckhoute J; Carroll JS; Geistlinger TR; Torres-Arzayus MI; Brown M
    Genes Dev; 2006 Sep; 20(18):2513-26. PubMed ID: 16980581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity.
    Wang C; Fan S; Li Z; Fu M; Rao M; Ma Y; Lisanti MP; Albanese C; Katzenellenbogen BS; Kushner PJ; Weber B; Rosen EM; Pestell RG
    Cancer Res; 2005 Aug; 65(15):6557-67. PubMed ID: 16061635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast cancer cells.
    Mauro L; Pellegrino M; Giordano F; Ricchio E; Rizza P; De Amicis F; Catalano S; Bonofiglio D; Panno ML; Andò S
    FASEB J; 2015 May; 29(5):2150-60. PubMed ID: 25657113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells.
    Suh JH; Gong EY; Kim JB; Lee IK; Choi HS; Lee K
    Mol Cancer Res; 2008 Feb; 6(2):314-24. PubMed ID: 18245227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.
    Recchia AG; Musti AM; Lanzino M; Panno ML; Turano E; Zumpano R; Belfiore A; Andò S; Maggiolini M
    Int J Biochem Cell Biol; 2009 Mar; 41(3):603-14. PubMed ID: 18692155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.